| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 01/18/2007 | WO2007006724A1 5-alkyl-7-amino-6-heteroaryl-1,2,4-triazolo[1,5-a]pyrimidine compounds and use thereof for the prevention of fungal pests |
| 01/18/2007 | WO2007006723A1 7-amino-6-tetrazolyl-1,2,4-triazolo[1,5-a]pyrimidine compounds and their use for controlling pathogenic fungi |
| 01/18/2007 | WO2007006722A1 2-substituted 7-amino-6-heteroaryl-1, 2, 4-triazolo [1, 5-a] pyrimidine compounds and the use thereof for controlling pathogenic fungi |
| 01/18/2007 | WO2007006717A1 Substituted rylene derivatives |
| 01/18/2007 | WO2007006714A1 Cysteine protease inhibitors |
| 01/18/2007 | WO2007006566A1 Pyridazine compounds as glycogen synthase kinase 3 inhibitors |
| 01/18/2007 | WO2006124581A3 Pyrrolobenzodiazepines and heterocyclic carboxamide derivatives as follicle stimulating hormone receptor (fsh-r) antagonists |
| 01/18/2007 | WO2006120552A3 ANHYDROUS CRYSTALLINE FORMS OF N-[1-(2-ETHOXYETHYL)-5-(N-ETHYL-N-METHYLAMINO)-7-(4-METHYLPYRIDIN-2-yl-AMINO)-1H-PYRAZOLO[4,3-d]PYRIMIDINE-3-CARBONYL]METHANESULFONAMIDE |
| 01/18/2007 | WO2006017443A3 Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds |
| 01/18/2007 | US20070015819 Novel compounds |
| 01/18/2007 | US20070015812 Factor Xa inhibitors |
| 01/18/2007 | US20070015784 Subsitituted 1,4,8- triazaspiro [4,5]decan-2-one compounds |
| 01/18/2007 | US20070015783 Substituted 1,4,8-triazaspiro[4,5]decan-2-one compounds |
| 01/18/2007 | US20070015781 Certain substituted spirocyclic lactams and use thereof as pharmaceuticals |
| 01/18/2007 | US20070015776 Kinase Inhibitors |
| 01/18/2007 | US20070015772 Nucleoside metabolism inhibitors |
| 01/18/2007 | US20070015771 Lonidamine analogs |
| 01/18/2007 | US20070015764 Inhibits hepatitus virus replication; useful in therapeutic and prophylactic treatment of hepatitis C virus |
| 01/18/2007 | US20070015760 Intermediates useful in preparing certain pyrrolotriazine compounds and process for making such intermediates |
| 01/18/2007 | US20070015746 Azepine derivaties as pharmaceutical agents |
| 01/18/2007 | US20070015742 Porphyrin derivatives |
| 01/18/2007 | US20070015664 2,4,6-Phenyl substituted cyclic ketoenols |
| 01/18/2007 | US20070015207 Such as 1-dimethylamino-3-[4-(3-indan-5-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-ylamino)-phenoxy]-propan-2-ol; serine-tyrosine and tyrosine kinase inhibitors; cancer, metastasis |
| 01/18/2007 | US20070014737 Administering quinine, chlorzoxazone, cyclobenzaprine, carisoprodol via vaporization |
| 01/18/2007 | CA2614582A1 New derivatives of heptaazaphenalene, methods for obtaining them, and their use as protecting agents against uv radiation |
| 01/18/2007 | CA2614385A1 Pyridazine compounds as glycogen synthase kinase 3 inhibitors |
| 01/17/2007 | EP1743885A2 TNF-Alpha Produktion Hemmer zur Behandlung von Autoimmunerkrankungen |
| 01/17/2007 | EP1742950A1 Pyrazolo[4,3-d] pyrimidines |
| 01/17/2007 | EP1742949A1 Novel-2-(piperazin-1-yl)-and-2-([1,4]diazepan-1-yl)-imidazo[4,5-d]pyridazin-4-one, production and use thereof as medicament for the treatment of diabetes mellitus |
| 01/17/2007 | EP1742944A1 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 01/17/2007 | EP1742937A2 Pyrrolopyrimidine derivatives for treating proliferative diseases |
| 01/17/2007 | EP1742907A2 Certain chemical entities, compositions, and methods |
| 01/17/2007 | EP1742642A2 Phosphonate analogs of hiv integrase inhibitor compounds |
| 01/17/2007 | EP1603914B1 Compounds having activity at 5ht2c receptor and uses thereof |
| 01/17/2007 | EP1537117B1 Benzotriazabicyclic derivatives and use thereof as beta-lactamase inhibitors and anti-bacterial agents |
| 01/17/2007 | EP1532148B1 Novel purine- or pyrrolol(2,3-d)pyrimidine-2-carbonitiles for treating diseases associated with cysteine protease activity |
| 01/17/2007 | EP1341531B1 Lactam compound to inhibit beta-amyloid peptide release or synthesis |
| 01/17/2007 | EP1070068B2 Granulatimide derivatives for use in cancer treatment |
| 01/17/2007 | CN1898247A Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 01/17/2007 | CN1898246A Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine |
| 01/17/2007 | CN1898245A Process for the preparation of triazolopyrimidines |
| 01/17/2007 | CN1898244A Triazole derivatives as vasopressin antagonists |
| 01/17/2007 | CN1898243A Bicyclic heterocyclic p-38 kinase inhibitors |
| 01/17/2007 | CN1898242A 6-(2-chloro-4-alkoxy-phenyl)-triazolopyrimidines, method for the production thereof and its utilization for controlling fungi and agents contained therein |
| 01/17/2007 | CN1898241A 6-(2-chloro-4-alkoxy-phenyl)-triazolopyrimidines, method for the production thereof and its utilization for controlling fungi and agents contained therein |
| 01/17/2007 | CN1898240A Imidazopyrazine tyrosine kinase inhibitors |
| 01/17/2007 | CN1898216A Amide derivatives |
| 01/17/2007 | CN1898201A Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
| 01/17/2007 | CN1897928A Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 01/17/2007 | CN1896078A Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors |
| 01/17/2007 | CN1896076A Tricyclic-type compound, and medicine having it as effective component |
| 01/17/2007 | CN1895673A The use of substituted tetracyclic imidazole derivatives as anti-histaminics |
| 01/16/2007 | US7164019 Such as cyclopentanecarboxylic acid {(S)-1-phenyl-3-[5-(pyridine-3-carbonyl)-hexahydro-pyrrolo[3,4-c]pyrrol-2-yl]-propyl}-amide; antagonists of chemokine receptors, useful for treating/preventing human immunodeficiency virus infection, AIDS or ARC |
| 01/16/2007 | US7163956 Substituted fullerene compositions and their use as antioxidants |
| 01/16/2007 | US7163943 e.g., 6-(3-Chloro-4-methoxy-phenoxy)-N-cycloheptyl-N'-methyl-N'-(1-methyl-piperidin-4-yl)-[1,3 ,5]triazine-2,4-diamine; inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells and inhibit smooth muscle proliferation. |
| 01/16/2007 | US7163939 important in the progression of many disease states that are induced by the inappropriate proliferation of cells; anticancer agent |
| 01/16/2007 | US7163937 Cyclic derivatives as modulators of chemokine receptor activity |
| 01/16/2007 | US7163936 β-lactam compounds and process for producing the same |
| 01/16/2007 | US7163772 including a novel mu -oxo bridged heterometal compound as a charge generating material |
| 01/11/2007 | WO2007005709A1 Intermediates useful in preparing certain pyrrolotriazine compounds and process for making such intermediates |
| 01/11/2007 | WO2007005708A1 Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith |
| 01/11/2007 | WO2007005631A1 Pyrrolotriazine compounds useful as kinase inhibitors |
| 01/11/2007 | WO2007005630A1 Pyrrolotriazine compounds useful as kinase inhibitors |
| 01/11/2007 | WO2007004954A1 [1, 2, 4] triazolo [1, 5-a] pyrimidine derivatives as chromatographic adsorbent for the selctive adsorption of igg |
| 01/11/2007 | WO2007004749A1 Fused heterocyclic derivatives and use thereof |
| 01/11/2007 | WO2007003536A1 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect |
| 01/11/2007 | WO2007002981A1 Red-shifted water-dispersible ir dyes |
| 01/11/2007 | WO2007002980A1 Red-shifted water-dispersible naphthalocyanine dyes |
| 01/11/2007 | WO2006117396A3 Process for preparing chlorides of phthalocyanine derivatives comprising at least a quaternary ammonium group |
| 01/11/2007 | WO2006020959A3 Substituted benzofused heterocycles |
| 01/11/2007 | WO2006009734A8 Gonadotropin releasing hormone receptor antagonists |
| 01/11/2007 | WO2005123742A3 A new route to formyl-porphyrins |
| 01/11/2007 | US20070010672 Inks, colorants, pigmented plastics for coatings, non-impact-printing material, color filters, cosmetics, polymeric ink particles, toners, fluorescent tracers; high in the efficiency of electrical energy utilisation and high in luminance |
| 01/11/2007 | US20070010670 Nitrogen-containing fused ring compounds and use thereof |
| 01/11/2007 | US20070010557 Novel amides useful for treating pain |
| 01/11/2007 | US20070010539 Ethyl-1'-[(2S)-2-hydroxy-2-phenylethyl]-6'-oxo-8'-(pyridin-4-yl)-1',3',4',6'-tetrahydro-1H-spiro[piperidine-4,2'-pyrimido[1,2-a]pyrimidine]-1-carbox; glycogen synthase kinase-3 beta, amyloid precursor protein, tau protein hyperphosphorylation inhibitor; neurodegenerative disease, type II diabetes |
| 01/11/2007 | US20070010524 Azaindazole compounds and methods of use |
| 01/11/2007 | US20070010523 Azaindazole compounds and methods of use |
| 01/11/2007 | US20070010522 Triazolo[1,5-c]pyrimidines and pyrazolo[1,5-c]pyrimidines useful as a2a adenosine receptor antagonists |
| 01/11/2007 | US20070010521 Condensed polycyclic compounds |
| 01/11/2007 | US20070010520 Triazolopyrazines and methods of making and using the same |
| 01/11/2007 | US20070010515 [1,2,4] Triazolo [1,5, a] pyrimidin-2-ylurea derivative and use thereof |
| 01/11/2007 | US20070010510 4-Substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof |
| 01/11/2007 | US20070010509 Cycloamine ccr5 receptor antagonists |
| 01/11/2007 | US20070009980 Continuous fluorogenic analyte assays with dendritic amplification of signal |
| 01/11/2007 | US20070009442 Macrocyclic metal complexes and their use for the production of conjugates with biomolecules |
| 01/11/2007 | US20070006772 Cyan dye for ink-jet |
| 01/11/2007 | CA2627592A1 [1, 2, 4] triazolo [1, 5-a] pyrimidine derivatives as chromatographic adsorbent for the selective adsorption of igg |
| 01/11/2007 | CA2613895A1 Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith |
| 01/11/2007 | CA2613059A1 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect, process for their manufacture and use thereof as medicaments |
| 01/11/2007 | CA2611438A1 Cyclic anilino-pyridinotriazines |
| 01/10/2007 | EP1741756A1 Tetraazaporphyrin compound |
| 01/10/2007 | EP1741713A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 01/10/2007 | EP1741703A1 Pyridone derivative |
| 01/10/2007 | EP1740673A1 Triazole derivatives and use therof in organic light-emitting diodes(oleds) |
| 01/10/2007 | EP1740593A1 Processes for the preparation of clopidogrel hydrogen sulfate polymorphic form i |
| 01/10/2007 | EP1740591A1 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 01/10/2007 | EP1740590A1 PYRAZOLO [3,4- b] PYRIDINE COMPOUNDS, AND THEIR USE AS PDE4 INHIBITORS |
| 01/10/2007 | EP1740589A1 Novel 2-amino-imidazo[4,5-d]pyridazin-4-ones and 2-amino-imidazo[4,5-c]pyridin-4-ones, production and use thereof as medicaments |
| 01/10/2007 | EP1740588A2 Reverse-turn mimetics and method relating thereto |